Infectious Diseases

< Back

Overview

The aim of the seven groups of this area is to improve the outcomes of patients with infectious diseases. The Epidemiology and Public Health group is mainly focused on the epidemiology and prevention of healthcare acquired infections, transmissible infections and on the new preventive vaccines. The Infectious Diseases group focuses on improving the strategies of clinical problems observed in clinical practice. Microbiology studies mechanisms of resistance to antimicrobials, pathogenicity, taxonomy and epidemiology, and infectious diseases diagnostics.

The CRIPS group focuses on the most prevalent aspects of infections in the intensive care unit (ICU), while SODIR group works in the areas of shock, organ dysfunction and resuscitation.

There is also a group focused on infection in immunocompromised pediatric patients, and a group from the CIBBIM-Nanomedicine interested in the synthesis, characterization and applications of engineered inorganic nanoparticles in the field of medicine.

Publications

236
total
1,029.655
impact factor
4.363
average impact factor

Director: Pere Soler Palacin

The group has consolidated its structure along 2017 and we are currently leading national and European projects on Zika infection in children and gene therapy in primary immunodeficiencies. The consolidation of the group has allowed our involvement in eight currently active clinical trials, and other seventeen active research projects and an increase in the number of publications and its resulting impact factor. During 2017, in addition to previous recognitions, our group has been recognized as the reference unit for SCID newborn screening in Catalonia, a pioneer project in Europe and as a pre-consolidated group by the AGAUR. Moreover, we have five-fold increased our funding from the 2008-2013 to 2014-2016 period. Finally, our close relationship with the patients’ associations and regional foundations brings a central role to patients and their families in conducting responsible research.

VHIR Annual Report 2017